In the U.S. Senate system, sometimes the fate of an entire federal agency with nearly 12,000 employees rests on the vote of just one person. That is precisely the situation facing Dr. Erica Schwartz after a hearing lasting more than two hours before the Senate Committee on Health, Education, Labor and Pensions on July 15, 2026, an event that the committee had announced in advance from early July. The committee currently has 12 Republican seats and 11 Democratic seats, meaning that if the entire Democratic caucus votes in opposition, just one wavering Republican senator would be enough to block her nomination, according to lailluminator.com.
That uncertainty is no accident. It reflects a leadership vacuum that has persisted throughout much of President Donald Trump's second term: the Centers for Disease Control and Prevention (CDC) has lacked a permanent director for an extended period, and Schwartz is his third choice for the position, according to NPR.
He felt that Schwartz consistently tried to avoid giving straight answers to questions, something that the committee chairman from her own party called disappointing.
Why the CDC director position has become a political minefield
To understand why a candidate with degrees in medicine, law, and public health, who previously served as a Navy rear admiral and Deputy Surgeon General under Trump's first term, is struggling to secure votes, one must look back at her predecessors. Trump's first nominee, Dr. Dave Weldon, withdrew just before his hearing due to insufficient votes, according to NPR. His second nominee, Susan Monarez, was confirmed by the Senate but held the position for less than a month before being fired by Health and Human Services Secretary Robert F. Kennedy Jr. after she refused to approve vaccine recommendations or dismiss professional staff without clear justification, according to lailluminator.com.
Monarez's shadow hung over the hearing room on July 15. Senator Bill Cassidy, a Republican from Louisiana and committee chair, directly asked Schwartz whether she would follow Monarez's path — that is, whether she would dare say no to political pressure from her own agency leadership. In his opening statement, Cassidy emphasized that the committee needs leaders without bias, making decisions based on science rather than politics or ideology, according to lailluminator.com.
Evasive answers and a disappointed committee chair
What was most striking about the hearing was not what Schwartz committed to, but how she avoided answering directly. After more than two hours of questioning, Cassidy himself — a member of her own party — publicly stated that he believed administration officials had prepared her so thoroughly that some of her answers strayed from the substance of the questions, and he felt Schwartz continuously tried to avoid direct responses, which he described as disappointing, according to lailluminator.com.
This is no minor detail. When a committee chair from the party in power publicly expresses disappointment with how a nominee answers questions, it is a clear signal that confirmation votes are no longer a foregone conclusion. On substance, Schwartz did provide scientifically grounded commitments: she said she would never betray science, would accept evidence showing vaccines do not cause autism, and affirmed that mRNA vaccine technology is safe and effective, according to lailluminator.com. She also said her top priority if confirmed would be restoring public trust in public health agencies through complete transparency, according to NPR.
The problem is that these statements contradict her recent history. Earlier this year, Schwartz had publicly supported vaccines as a disease prevention tool and maintained military readiness on Instagram — but that personal account was deleted immediately after she was nominated for the CDC director position, according to NPR. With a committee that has just weathered the Monarez shock, a nominee who erased evidence of personal views before her hearing is not a good sign for the scientific independence that Cassidy demands.
Kennedy is a bigger variable than the nominee
The entire Schwartz story cannot be separated from Kennedy's position at the Department of Health and Human Services. Just one day after Schwartz's hearing, Kennedy himself had to appear before the Senate Finance Committee to answer questions about controversy surrounding vaccine recommendations still pending at the CDC, according to Slate Magazine. At that hearing, Cassidy — who cast the deciding vote helping Kennedy get confirmed after receiving specific assurances about vaccine policy — publicly pressed Kennedy on whether he had kept those promises, according to Slate Magazine. Kennedy had canceled 500 million dollars in mRNA vaccine development funding, and when Cassidy concluded that Kennedy was restricting Americans' access to vaccines, Kennedy replied that Cassidy was wrong.
That context explains why the CDC director position is not simply an administrative role. Whoever sits in that chair must answer to two masters: public science and Kennedy's political will. Internal CDC emails released by Senator Bernie Sanders show a series of high-level exchanges among CDC officials during the chaotic period leading to Monarez's firing, according to NPR. During the period these emails were exchanged, the CDC lost thousands of employees due to budget cuts and voluntary resignations, according to NPR.
That is why the real question is not whether Schwartz is qualified — no one doubts that — but whether she has the political fortitude to survive longer than one month like Monarez. Senate Majority Leader John Thune has publicly expressed concern about spending Senate time confirming CDC directors whom Kennedy could fire at any time, according to Slate Magazine — a statement showing that even within the Republican Party, confidence in this process has fractured.
Small details reveal real policy priorities
Beyond the vaccine battle, two other details from the hearing suggest the pragmatic direction some senators want to push Schwartz toward. Senator Josh Hawley of Missouri asked her to investigate potential health impacts for people living near data centers — Schwartz acknowledged not knowing whether the National Institute for Occupational Safety and Health, an agency within the CDC, had ever studied the issue but committed to coordinating with Hawley's office if confirmed, according to lailluminator.com.
Hawley also requested that the CDC collect complete abortion data from all states. In reality, the CDC currently only operates a voluntary reporting system called the Abortion Surveillance System, and some states do not provide data to this system, resulting in an incomplete national picture of abortion, according to lailluminator.com. Schwartz called this surveillance a core part of the CDC's current work — a statement revealing that reproductive health data remains a major political flashpoint even in a hearing ostensibly focused on vaccines.
At the same time, other tensions within the Trump executive branch surfaced: six Democratic senators, including Elissa Slotkin, Ruben Gallego, Gary Peters, Andy Kim, Maggie Hassan, and Richard Blumenthal, sent a letter requesting the removal of Paul Ingrassia from his position at the General Services Administration (GSA), arguing that his continued work in government is unacceptable, according to Washington Examiner. This is a separate matter, but it demonstrates a pattern repeating in Trump's second term: the Senate, even when controlled by Republicans, increasingly must resort to public pressure to force the administration to account for key personnel.
Why CDC instability matters beyond Washington
For Vietnamese American families in the United States, the CDC is no stranger to the news — it is the source of vaccine recommendations for young children, guidance on winter respiratory disease prevention, and data that family doctors in Little Saigon in San Jose or Houston rely on to counsel elderly patients. When the CDC director position becomes a revolving seat constantly turning over — three nominees in less than two years, one fired after less than a month — the continuity of public health recommendations is threatened. For a community where many elderly people depend on Medicare Part B to pay for flu, pneumococcal, or shingles vaccines, fluctuations in vaccine policy at the federal level can translate into fluctuations in affordability and the reliability of recommendations their doctors provide at the clinic.
The matter carries another layer of meaning. Many Vietnamese refugee families once lived under a political system where expert opinion had to bow to political directives — so when they follow news of the ongoing tensions between CDC scientific officials and political superiors at HHS, many instinctively harbor doubts about the agency's independence, regardless of who occupies the White House. That is why the Schwartz story, though it may sound like internal Senate business, touches on a generational concern in the community: whether public science can still be protected from political interference.
Conclusion: Schwartz is likely to be confirmed, but at a cost
While the hearing